Rebalix
Logo InvescoInvesco · sheet of 5 September 2026
ETF sheet · official issuer and register data

Invesco Energy S&P US Select Sector UCITS ETF Acc

XLES · IE00B435CG94 · class Acc · USD · domicile Ireland
Equity · North America · EnergySFDR art. 6
Index tracked: S&P® Select Sector Capped 20% Energy Index
TER
0.14%+ trans. 0.00%
Fund size
126 m EUR
Tracking difference
+0.39%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Accumulating
Launch 16 Dec 2009 · costs from the KID as of 14 Aug 2026 · 77 securities held · 4 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Redemption and Dealing of Shares: The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in accordance with the redemption procedures set out in the prospectus, subject to any applicable laws and relevant charges. Investment objective: The objective of the Fund is to achieve the net total return performance of…

Performance since series start (in euro) — base 100

16 Dec 200911 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
20102013201620192022202542469416
High 424 (27 Mar 2026) · low 69 (23 Mar 2020) · last 416. Past performance is not indicative of future results.

Returns in euro

1 year+48.4%
3 years+39.6%
5 years+191.1%
10 years+148.5%
Since series start+315.8%

Risk · 1 / 3 / 5 years

Volatility (ann.)21.76%21.75%25.92%
Max drawdown−14.94%−20.35%−26.80%
Sharpe1.890.630.92
Sortino2.820.861.30
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · XLES · IE00B435CG941
RebalixXLES · IE00B435CG94 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+7.03%+6.62%+0.40%
2024+4.49%+4.12%+0.37%
2023−1.17%−1.56%+0.40%
2022+63.01%+62.21%+0.80%
2021+53.80%+53.00%+0.80%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 77 securities · top-10 weight = 46.3%
Top holdingsWeight
MOLINA HEALTHCARE INC7.1%
PERFORMANCE FOOD GROUP CO7.0%
NETFLIX INC6.6%
DEVON ENERGY CORP5.0%
SEMTECH CORP3.9%
HOWMET AEROSPACE INC3.6%
CORECIVIC INC3.4%
MICRON TECHNOLOGY INC3.4%
WALT DISNEY CO/THE3.3%
ULTRAGENYX PHARMACEUTICAL IN3.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
XLES · Borsa Italiana (ETFplus)
SML9 · Börse Düsseldorf, Börse Hamburg, Börse München / gettex
+ 12 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE00B435CG94
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · XLES · IE00B435CG942